Crewe Advisors LLC bought a new position in Xylem Inc. (NYSE:XYL – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,200 shares of the industrial products company’s stock, valued at approximately $155,000.
Other institutional investors have also added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of Xylem during the fourth quarter worth approximately $198,207,000. Artisan Partners Limited Partnership bought a new stake in shares of Xylem in the 4th quarter worth approximately $187,207,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its holdings in shares of Xylem by 1,503.7% in the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,649,926 shares of the industrial products company’s stock worth $188,685,000 after acquiring an additional 1,547,043 shares during the last quarter. Kodai Capital Management LP bought a new stake in shares of Xylem in the 4th quarter worth approximately $133,945,000. Finally, Balyasny Asset Management L.P. lifted its holdings in shares of Xylem by 4,769.0% in the 4th quarter. Balyasny Asset Management L.P. now owns 927,390 shares of the industrial products company’s stock worth $106,056,000 after acquiring an additional 908,343 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on XYL. Robert W. Baird boosted their price objective on shares of Xylem from $151.00 to $155.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Citigroup lifted their target price on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research note on Monday, April 8th. Mizuho lifted their target price on shares of Xylem from $110.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, May 3rd. Oppenheimer lifted their target price on shares of Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Finally, Royal Bank of Canada lifted their target price on shares of Xylem from $157.00 to $162.00 and gave the stock an “outperform” rating in a research note on Friday, May 3rd. Five analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $144.58.
Insider Transactions at Xylem
In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the completion of the sale, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the completion of the sale, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the sale, the senior vice president now directly owns 76,287 shares of the company’s stock, valued at $10,604,655.87. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.
Xylem Stock Performance
XYL traded up $0.42 during midday trading on Thursday, hitting $137.13. 1,239,149 shares of the company traded hands, compared to its average volume of 1,196,844. The company has a quick ratio of 1.22, a current ratio of 1.67 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $33.25 billion, a PE ratio of 48.80, a price-to-earnings-growth ratio of 2.50 and a beta of 1.04. The company’s 50-day moving average is $138.60 and its 200 day moving average is $130.08. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $146.08.
Xylem (NYSE:XYL – Get Free Report) last posted its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.06. The business had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2 billion. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The business’s revenue for the quarter was up 40.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.72 EPS. On average, research analysts expect that Xylem Inc. will post 4.22 EPS for the current year.
Xylem Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th were paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 1.05%. The ex-dividend date of this dividend was Thursday, May 30th. Xylem’s dividend payout ratio (DPR) is presently 51.25%.
Xylem Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
- Five stocks we like better than Xylem
- How to Invest in Biotech Stocks
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- About the Markup Calculator
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- What is an Earnings Surprise?
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.